UK’s Leading Management Consultants 2021

18th February 20211 Minutes

Ranked in the Top 20 of the UK’s consulting firms, we are delighted to have been recognised for the third consecutive year as one of the ‘UK’s Leading Management Consultants 2021’ by the Financial Times.   

Recommended in seven categories compiled with data company Statista, the annual rating is based on endorsements by clients and peers and demonstrates our steady consistent year on year sector & service line growth.

Consulting companies are awarded Bronze (recommended), Silver (frequently recommended) or Gold (very frequently recommended).

Sectoral expertise

  • Construction & Infrastructure – Silver
  • Financial Services – Bronze
  • Healthcare – Bronze
  • Public & Social Sector – Bronze

Consulting services

  • Digital Transformation – Bronze
  • Operations & Supply Chain – Bronze
  • Strategy – Silver

Managing Partner Andrew Morgan said

We are thrilled to see the continued progression of the firm, competing alongside some major consulting brands.  I am really proud of the team and this reinforces their dedication to deliver tangible results for our clients in a range of markets through strategic, operational and transformational delivery.

CONTACT US TO FIND OUT HOW WE CAN HELP

Contact us

Future of work: healthcare med reps transformation

16th February 2021

In his latest blog post relating to Future of Work, Curzon’s Managing Consultant Rodrigo Quezada Dighero focuses on the transformation of healthcare medical sales reps.

Exploring how the pandemic has disrupted the face-to-face salesforce, and the unique opportunity this presents to adapt the operating model for future success.

The effectiveness of a disrupted salesforce

One year into the pandemic and face-to-face sales look very different from 12 months ago.  Medical Reps are facing exceptional challenges in reaching their sales targets, as restrictions on in-person meetings with HCPs continue.   

The gravity of the situation is reflected in the 16 new drugs launched during COVID-19 lockdowns, that are at risk of sales failures, according to one pharma consulting group.

However, the lifting of lockdowns is unlikely to return the industry back to ‘normal’.  In fact, the evidence shows a stark reality for in-person sales.

  • About 60% of surgeons believe that restrictions on in-person sales are likely to remain even after a Covid-19 vaccine is available and lockdown restrictions abate. 

 

Percentage who believe restrictions on face-to-face visits are likely to continue after Covid-19

Moreover, the changing landscape is not just a result of the pandemic; it’s expedited the necessary changes, but fundamentally, companies have been very slow to adapt their operating models to address the needs and wants of their customers and workforce.  

  • Of the 75% of physicians who preferred in-person visits from Medtech representatives prior to Covid-19, 47% would now opt for a virtual exchange or less-frequent visits. 

  • Many physicians once sceptical of any virtual interaction with sales reps now report these exchanges are high quality and offer a much better experience. 

Healthcare providers are demanding more from pharma, as they seek greater value from their interactions with Med Reps.

  • 69% of doctors now want digital patient education 

  • 67% want more education on remote patient care 

  • 65% need specific information on conditions relative to COVID-19

  • 65% require information to help patients access labs, tests and imaging

It’s clear as medical professionals endure the uncertainty caused by COVID-19, changes are here to stay, and adaptation is crucial to success.

Identifying the opportunity - a new way of working

Digitalisation has accelerated the Next Normal requiring pharma operating models to adapt, or in some cases, completely transform to help them to thrive or even survive.

In this context, the need to provide refined, enriched collateral to healthcare providers and doctors demands an evolution from face-to-face meetings and conferences into a hybrid exchange of virtual and in-person meetings, steered by medical reps.

Percentages of doctors who prefer in-person sales visits

However, in order for this to be fully realised, pharma companies need to adjust and develop their salesforce capabilities.  In another study, research shows that only 26% of pharma reps get coaching personalised to their needs. A focus on sales coaching, through integrated, personalised and value-driven interactions will support med reps to identify target prospects and align the products to the needs of the HPC, through their preferred communication channel.

Moreover, managers and leaders need to align sales & marketing, to ensure a collaborative approach to fully understand the customers and the local market they operate in. Communication and insight must flow both ways to drive communication strategies, content creation and support product development.

Our approach

Our approach to New Ways of Working accelerates the adaptation to the digital business model, focusing on the delivery of required capabilities and the evolution towards a hybrid model. 

For this specific transformation, we focus on four of the five key areas

  • Organisation

  • Collaboration and Hybrid Solutions

  • Smartworking Processes

  • People & Leadership

Organisation

  • Develop strategies that assist medical reps throughout the sales process, tailored to every customer touchpoint.
  • Establish hybrid teams that can develop relevant, channel-specific, timely content to empower the med reps.
  • Foster internal engagement and alignment by creating a purpose-based organisation with a relentless focus on value-add customer service. 
  • Entrench company culture to sustain new ways of working and improve business agility – always listening… constantly evolving.

Collaboration & Hybrid Solutions

The virtual nature of teams and work communities spearheads the need to adopt solutions that enhance and facilitate effective remote interactions.

  • Optimise team relationships, roles & interactions to enhance hybrid ways of working.
  • Design and implement collaboration solutions applied to the business and team leadership.
  • Adopt collaborative tools, enabling sales & marketing teams to share opportunities that improve the quality of exchanges, content creation and value-based interactions regardless of location.

Smartworking Processes

Achieving process transformation through re-engineering & automation to create a generation of agile, flexible, efficient and collaborative working dynamics.

  • Redesign smartworking processes, harnessing automation and flexibility to accelerate change and bring the hybrid model alive.
  • Employ digital tools to evolve sales, HCP engagement and bring the customer experience to the forefront of every interaction.
  • Remove silos to cultivate employee engagement and shared knowledge/opportunities.

People & Leadership

Evolution of culture and people is the foundation of Digital Transformation enabling leaders of pharma companies to steer a change in behaviour and actions.

  • Adapt the hybrid model and embed culture based on learning and sharing.
  • Develop salesforce capabilities with a focus on digital skills, converging efforts to support sales requirements through content creation and content sharing.
  • Embed a coaching culture that fosters learning and sharing.
  • Deploy cultural change that embraces and cements the New Normal.

The time to act is now

We work with pharma businesses to deliver New Ways of Working that accelerate the adaptation to the digital business model.  Ultimately our work helps businesses to grow, improve customer retention and discover new opportunities.

Ask us how we can help your organisation to transition into the New Ways of Working putting your salesforce ahead of the curve.

Contact us

CONTACT US TO FIND OUT HOW WE CAN HELP

Contact us